Advanced search    

Search: authors:"Kim Cocks"

8 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

A Q-TWiST Analysis Comparing Nivolumab and Therapy of Investigator’s Choice in Patients with Recurrent/Metastatic Platinum-Refractory Squamous Cell Carcinoma of the Head and Neck

version for publication. Compliance with Ethical Standards Funding This study was supported by Bristol-Myers Squibb. Conflict of interest Kim Cocks, Sarah Simpson, and Fiona Taylor are employees of ... Adelphi Values, which has received payment from Bristol-Myers Squibb for contracted analyses. Kim Cocks has also received personal fees from Amgen, AstraZeneca, Celgene, EndoMag, and Onyx Pharmaceuticals

The patient reporting and action for a safe environment (PRASE) intervention: a feasibility study

Background There is growing interest in the role of patients in improving patient safety. One such role is providing feedback on the safety of their care. Here we describe the development and feasibility testing of an intervention that collects patient feedback on patient safety, brings together staff to consider this feedback and to plan improvement strategies. We address two...

International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia

Purpose This paper describes the international, cross-cultural development of four disease-specific EORTC QoL questionnaires, to supplement the EORTC QLQ-C30, for patients with Hodgkin lymphoma (HL), high- or low-grade non-Hodgkin lymphoma (HG/LG-NHL), and CLL. Methods Questionnaire development was conducted according to guidelines from the EORTC Quality of Life Group. Phase I...

An intervention to reassure patients about test results in rapid access chest pain clinic: a pilot randomised controlled trial

Background Most people referred to rapid access chest pain clinics have non-cardiac chest pain, and in those diagnosed with stable coronary heart disease, guidance recommends that first-line treatment is usually medication rather than revascularisation. Consequently, many patients are not reassured they have the correct diagnosis or treatment. A previous trial reported that, in...

Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial

trial Sarah R Kingsbury 0 Puvan Tharmanathan Nigel K Arden Michael Batley Fraser Birrell Kim Cocks Michael Doherty Chris J Edwards Toby Garrood Andrew J Grainger 0 Michael Green Catherine Hewitt Rod